In 1968, Ortho introduced RhoGAM Rho(D) immune globulin, the first medication developed to prevent Rh hemolytic disease of the newborn.
William Pollack (February 26, 1926 – November 3, 2013) was a British-born American immunologist who developed the Rho(D) immune globulin vaccine against Rh disease, a leading cause of erythroblastosis fetalis.
Parkinson's disease | Alzheimer's disease | Centers for Disease Control and Prevention | Huntington's disease | Centers for Disease Control | Bright's disease | Dutch elm disease | disease | Crohn's disease | Chagas disease | sexually transmitted disease | Plague (disease) | Chronic obstructive pulmonary disease | Sexually transmitted disease | Lyme disease | Gaucher's disease | cardiovascular disease | Asbestos Disease Awareness Organization | Alzheimer's Disease | Paget's disease of bone | Motor Neurone Disease Association | Graves' disease | End stage renal disease | chronic obstructive pulmonary disease | Chronic kidney disease | chronic kidney disease | Cardiovascular disease | Batten disease | Tay-Sachs disease | Schilder's disease |
1980 - Finn, together with Cyril Clarke, John Gorman, Vincent Freda, and William Pollack were jointly awarded the 1980 Albert Lasker Award for Clinical Medical Research for pioneering work on the Rhesus blood group system, the role of anti-RhD antibodies in the causation of Rh disease, and the prevention of Rh disease with anti-D antibodies.